TB-500 (Thymosin 4) is a 43-amino-acid peptide involved in cell migration, angiogenesis, and wound healing [3] [4]
S., Yokosuka, K., Sato, K
Originally approved for type 2 diabetes and later for obesity treatment, GLP-1 and other incretin-based therapies have rapidly gained traction in both clinical and consumer spaces
To be included, studies had to involve patients with a diagnosis of IIH according to established diagnostic (including modified Dandy or Friedman criteria) [16], administer a GLP-1 RA as an intervention, and report outcomes of interest such as ICP/CSF opening pressure, headache frequency/severity, visual function, weight/BMI, cognitive measures, and/or safety outcomes
They provide personalized advice on dietary changes and exercise that fit your life, rather than generic advice that treats everyone the same